Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)
Clinical trial NCT03547700 · TERMINATED
Trial details
- NCT number
- NCT03547700
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-26
- Primary completion
- 2020-08-27
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.